NGM Biopharmaceuticals Lands $20,710,000 Series D Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=539ddb0d-44d9-46e0-8a1e-8a1fb1fe190b - Date
2/24/2015 - Company Name
NGM Biopharmaceuticals - Mailing Address
630 Gateway Blvd South San Francisco, CA 94080 USA - Company Description
NGM is a privately-held drug discovery company committed to the identification and development of transformational biologics for diabetes, obesity, muscle wasting and other cardiometabolic diseases. - Website
http://www.ngmbio.com - Transaction Type
Venture Equity - Transaction Amount
$20,710,000 - Transaction Round
Series D - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
